Effectiveness of a Clinical Decision Support System for Reducing the Risk of QT Interval Prolongation in Hospitalized Patients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation. Cardiovascular Quality and Outcomes

• Publication date

  2014-05-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1161/CIRCOUTCOMES.113.000651PMID 24803473PMCID PMC4696749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients

  2013influential reference
• Institution-wide QT alert system identifies patients with a high risk of mortality.

  2013cited by this paper
• Circ Cardiovasc Qual Outcomes

  2013cited by this paper
• Prevalence of QT Interval Prolongation in Patients Admitted to Cardiac Care Units and Frequency of Subsequent Administration of QT Interval-Prolonging Drugs

  2012cited by this paper
• Clinical decision support for monitoring drug-drug-interactions and potassium-increasing drug combinations: need for specific alerts.

  2012cited by this paper
• High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: Results of the QT in Practice (QTIP) Study*

  2012cited by this paper
• Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

  2010cited by this paper
• Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.

  2010cited by this paper
• CENTER FOR DRUG EVALUATION AND RESEARCH

  2009cited by this paper
• Overrides of medication alerts in ambulatory care.

  2009cited by this paper
• Correction

  2009cited by this paper
• Accurate electrocardiographic assessment of the QT interval: teach the tangent.

  2008cited by this paper
• In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs.

  2007cited by this paper
• Long QT syndrome in adults.

  2007cited by this paper
• Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes.

  2007influential reference
• Prolonged QTc interval and risk of sudden cardiac death in a population of older adults.

  2006cited by this paper
• Overriding of drug safety alerts in computerized physician order entry.

  2006cited by this paper
• Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review.

  2005cited by this paper
• Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review.

  2005cited by this paper
• Risk stratification in the long-QT syndrome.

  2003cited by this paper
• Physicians' decisions to override computerized drug alerts in primary care.

  2003cited by this paper
• Risk stratification in the long-QT syndrome.

  2003cited by this paper
• Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes

  2001cited by this paper
• The long-QT syndrome.

  2000cited by this paper
• Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.

  1998cited by this paper
• Mechanism of the cardiotoxic actions of terfenadine.

  1993cited by this paper
• The Long QT Syndrome: Prospective Longitudinal Study of 328 Families

  1991cited by this paper
• Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.

  1986cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Safety of Hydroxychloroquine: What a Dermatologist Should Know

  2025cites this paper
• Risk Stratification of QTc Prolongations in Hospitalized Cardiology and Gastroenterology Patients Using the Tisdale Score—A Retrospective Analysis

  2025cites this paper
• Drug‐Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes

  2025cites this paper
• QT interval prolongation: clinical assessment, risk factors and quantitative pharmacological considerations

  2025cites this paper
• QT STAR: concomitant QTc-prolonging medication use among patients with HR+/HER2− metastatic breast cancer receiving a CDK4/6 inhibitor in first line

  2025cites this paper
• Major adverse cardiac events with haloperidol: A meta-analysis

  2025cites this paper
• Macrolide Antibiotic Mediated Cardiac Arrhythmias: Emerging Concepts and Clinical Implications

  2025cites this paper
• Major Adverse Cardiac Events with Ondansetron: A Systematic Review.

  2025cites this paper
• Impact of an Alert-Based Inpatient Clinical Decision Support Tool to Prevent Drug-Induced Long QT Syndrome: Large-Scale, System-Wide Observational Study

  2025cites this paper
• QTc Interval: A Frequently Unrecognized Electrocardiographic Interval.

  2024cites this paper
• The Effect of Computerized Alerts on Prescribing and Patient Outcomes: A Systematic Review

  2024cites this paper
• Things We Do for No Reason™: Checking QTc on hospitalized adult patients before intravenous ondansetron administration.

  2024cites this paper
• Determining sensitivity and specificity of risk scores for QTc interval prolongation in hemato-oncology patients prescribed systemic antifungal therapy: a retrospective cross-sectional study

  2024cites this paper
• A Calculated Risk: Evaluation of QTc Drug–Drug Interaction (DDI) Clinical Decision Support (CDS) Alerts and Performance of the Tisdale Risk Score Calculator

  2024cites this paper
• A polygenic risk score for the QT interval is an independent predictor of drug-induced QT prolongation

  2024cites this paper
• Proarrhythmic major adverse cardiac events with donepezil: A systematic review with meta‐analysis

  2024cites this paper
• Risk assessment tools for QT prolonging pharmacotherapy in older adults: a systematic review

  2022influential citation
• Relationship between a risk score for QT interval prolongation and mortality across rural and urban inpatient facilities.

  2022cites this paper
• Development in Prescriptions of Contraindicated and Potentially Harmful QT Interval–Prolonging Drugs in a Large Geriatric Inpatient Cohort From 2011 to 2021

  2022cites this paper
• Development and Validation of a Nomogram for Prediction of QT Interval Prolongation in Patients Administered Bedaquiline-Containing Regimens in China: a Modeling Study

  2022cites this paper
• Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis

  2022cites this paper
• QTc Prolongation in Poison Center Exposures to CredibleMeds List of Substances with “Known Risk of Torsades de Pointes”

  2022cites this paper
• Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de Pointes

  2022cites this paper
• Clinician Satisfaction With Advanced Clinical Decision Support to Reduce the Risk of Torsades de Pointes

  2022cites this paper
• Effect of Replacing Vendor QTc Alerts with a Custom QTc Risk Alert in Inpatients

  2022cites this paper
• Assessing Prescriber Behavior with a Clinical Decision Support Tool to Prevent Drug-Induced Long QT Syndrome

  2021cites this paper
• Drug-Induced QTc Prolongation: What We Know and Where We Are Going.

  2021cites this paper
• Development of a Risk Score for QT Prolongation in the Intensive Care Unit Using Time-Series Electrocardiogram Data and Electronic Medical Records

  2021cites this paper
• Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

  2021cites this paper
• Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data

  2021cites this paper
• Protocolo para la prevención de arritmias ventriculares debido al tratamiento en pacientes con COVID-19

  2020cites this paper
• Predictive Validity of a QTc Interval Prolongation Risk Score in the Intensive Care Unit

  2020cites this paper
• Preventive cardiology as a dedicated clinical service: The past, the present, and the (Magnificent) future

  2020cites this paper
• Emerging Pharmacotherapy and Health Care Needs of Patients in the Age of Artificial Intelligence and Digitalization

  2020cites this paper
• Estimates of population‐based incidence of malignant arrhythmias associated with medication use—a narrative review

  2020cites this paper
• Walk the Line—The Importance of Well-Informed Interpretation of QT Prolongation

  2020cites this paper
• PREVENTIVE CARDIOLOGY AS NEW SUBSPECIALTY OF CARDIOVASCULAR MEDICINE.

  2020cites this paper
• Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association.

  2020cites this paper
• Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts (EuRIDICE): study protocol for a prospective randomised multi-centre double-blind placebo-controlled clinical trial in the Netherlands

  2020cites this paper
• Intravenous haloperidol: A systematic review of side effects and recommendations for clinical use.

  2020cites this paper
• Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements

  2020cites this paper
• Drug Safety Issues in Therapy COVID-19

  2020cites this paper
• Protocolo para la prevención de arritmias ventriculares debido al tratamiento en pacientes con COVID-19./ Protocol for the prevention of ventricular arrhythmias due to treatment in COVID-19 patients.

  2020cites this paper
• The Importance of a Stepwise Unified Protocol in the Management of Hospitalized COVID-19 Patients: Clinical and Virological Evidence

  2020cites this paper
• Preventive Cardiology as Specialized Medical Art

  2020cites this paper
• Navigating the Minefield of QTc Interval‐Prolonging Therapy in Nursing Facility Residents

  2019cites this paper
• QT Assessment in Early Drug Development: The Long and the Short of It

  2019cites this paper
• Pharmacists and Cardiologists in the ACC.

  2019cites this paper
• QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia

  2019cites this paper
• Development of a predictive model for drug-associated QT prolongation in the inpatient setting using electronic health record data.

  2019cites this paper
• Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative Chlorobutanol

  2019cites this paper
• Prevalence and prognostic significance of prolonged QTc interval in emergency medical patients: A prospective observational study

  2018cites this paper
• Cardiovascular safety of prokinetic agents: A focus on drug‐induced arrhythmias

  2018cites this paper
• Pharmacogenetics and Pharmacogenomics in Cardiovascular Medicine and Surgery

  2018cites this paper
• An e-learning programme about the risk and management of QTc-prolongation in community pharmacies significantly improves pharmacists’ (long- term) knowledge

  2018cites this paper
• A literature-based algorithm for the assessment, management, and monitoring of drug-induced QTc prolongation in the psychiatric population

  2018cites this paper
• Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs

  2018cites this paper
• Reining in the QTc: reducing the risk of Torsades de Pointes across a major health system

  2018cites this paper
• QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications

  2018cites this paper
• Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review

  2018cites this paper
• CredibleMeds.org: What does it offer?

  2018cites this paper
• The clinical significance of QT prolongation associated with tamoxifen: A review of the literature

  2018cites this paper
• Drug‐induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and Pharmacy

  2018cites this paper
• Adverse Drug Event Causality Analysis (ADECA): A Process for Evaluating Evidence and Assigning Drugs to Risk Categories for Sudden Death

  2017cites this paper
• A prospective study on assessment of drug induced qt interval prolongationin inpatient department at a tertiary care hospital

  2017influential citation
• Impact of Pharmacist Intervention on Electrocardiogram Monitoring of Pediatric Patients on Multiple QTc Interval-Prolonging Medications.

  2017cites this paper
• Providers’ Response to Clinical Decision Support for QT Prolonging Drugs

  2017cites this paper
• Antimicrobials and QT prolongation.

  2017cites this paper
• Comparison of Overridden Medication-related Clinical Decision Support in the Intensive Care Unit between a Commercial System and a Legacy System

  2017cites this paper
• Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association

  2017cites this paper
• Sudden death: Neurogenic causes, prediction and prevention

  2017cites this paper
• Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation

  2016cites this paper
• Improving hospital drug safety Identification of medication errors and subsequent development , implementation and outcome evaluation of alert algorithms for their targeted prevention

  2016cites this paper
• Drug-induced QT interval prolongation and torsades de pointes

  2016cites this paper
• Medical decision support systems and therapeutics: The role of autopilots

  2016cites this paper
• Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes.

  2016influential citation
• Impact of the FDA Warning for Azithromycin and Risk for QT Prolongation on Utilization at an Academic Medical Center

  2016cites this paper
• The value of routine pharmacogenomic screening—Are we there yet? A perspective on the costs and benefits of routine screening—shouldn't everyone have this done?

  2016cites this paper
• Leveraging entrepreneurship as a means to improve the translation of outcomes research to healthcare improvement.

  2015cites this paper